Vaxcyte

Vaxcyte is a biotechnology company that develops vaccines, including a pneumococcal vaccine candidate, to compete in the pharmaceutical market.

Why it’s in the news: It is in the news for claiming success in its development of a new vaccine and for being part of increasing pharmaceutical M&A activity.

Latest on Vaxcyte

• STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
• STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more

Connections

7 entities linked to Vaxcyte across the news graph.